Background: Varicose veins is a common health problem, with an estimated prevalence of greater than 20% (range 21.8% to 29.4%). Approximately 5% (range 3.6% to 8.6%) have venous oedema, skin changes or ulceration. Chronic venous disease (CVD) is the most common venous disorder. It is caused by venous hypertension due to either reflux, outflow obstruction or both. Aim of the Work: The aim of the work was to review the feasibility and efficacy of catheter-directed foam sclerotherapy in treatment of saphenous vein incompetence. Patients and Methods: This clinical trial was conducted at vascular surgery department at Al Azhar University Hospital. The study included 25 patients suffering from primary varicose vein. All patients were belonging to class C2 to C4 Ep as Pr according to CEAP classification. This mean: C2 to C4 clinically stage to stage venous disease in which there were uncomplicated, moderate to severe varicosities. Ep etiologically the disease was primary with well functioning deep system. Anatomically, the varicosities affected the superficial system mainly the great saphenous vein. Results: Between March 2017 and March 2018, 25 patients (25 limbs) were treated with CDFS at vascular department -Al-Azhar University hospitals. Demographic data and severity of venous disease are shown in Table below . Conclusion: The use of this catheter based technique facilitated foam sclerotherapy with a high primary and acceptable short-term occlusion rates, and low numbers of complications. Further studies are required to evaluate how the migration of foam into the common femoral vein can be diminished and whether the techniques used in this study of leg elevation and manual compression provide any advantage.
INTRODUCTION
Varicose veins are a common health problem, with an estimated prevalence of greater than 20% (range 21.8% to 29.4%). Approximately 5% (range 3.6% to 8.6%) have venous oedema, skin changes or ulceration (1) . Chronic venous disease (CVD) is the most common venous disorder. It is caused by venous hypertension due to either reflux, outflow obstruction or both
(2)
. The clinical stages of varicose veins have been classified using the Clinical, Etiological, anatomical and Pathophysiological (CEAP) system. Simple varicose veins (CEAP classification C1 -C3) are more prevalent in women, with no significant gender differences being reported in the prevalence of severe varicose veins (C4 -C6)
(3)
. Diagnosis of primary varicose veins was carried out depending on patient history, physical examination and duplex scanning was considered the method of choice for the investigation of venous reflux. It combines the assessment of anatomic structure and the function evaluation of blood flow to enable quantification of reflux duration in specific superficial and deep vein segments. In addition, the choice of this method was as a noninvasive and repeatable method of measurement
(4)
. The treatment of primary varicose veins included conservative measures through leg elevation to reduce edema, venotonic drugs and elastic stocking. The Sclerotherapy was either traditional injection or foam sclerotherapy.
Operative measures included stripping with early and late complications. Endovenous measures included radiofrequency and laser ablation . The use of ultrasound guided foam sclerotherapy to treat varicose veins has rapidly increased during the last decade. Foam sclerotherapy is cheap, does not require anaesthesia, is effective and has an acceptable safety profile. The treatment rationale is that sclerosant agents damage the endothelium irreversibly by disrupting cell membranes resulting in sustained vasospasm and vessel obliteration.
The direct instillation of sclerosant agents as "microfoam" with air made became an attractive treatment for axial reflux in the great or small saphenous vein (GSV and SSV)
(6)
. A large number of reports have documented the potential advantages of this technique for treating incompetent axial veins .
AIM OF THE WORK
The aim of the work was to review the feasibility and efficacy of catheter-directed foam 4186 sclerotherapy in the treatment of saphenous vein incompetence.
PATIENTS AND METHODS
This clinical trial was conducted at vascular surgery department at Al Azhar University Hospital. The study included 25 patients suffering from primary varicose vein.
The study was approved by the Ethics Board of Al-Azhar University.
All patients were belonging to class C2 to C4 Ep as Pr according to CEAP classification. This mean: C2 to C4 clinically stage to stage venous disease in which there is uncomplicated moderate to sever varicosities. Ep etiologically the disease was primary with well functioning deep system. As anatomically the varicosities affected the superficial system mainly the great saphenous vein. Pr pathologically the disease was refluxing in nature.
Inclusion criteria
1-Symptomatic varicose vein: clinically from C2 to C4 from CEAP. 2-Incompetent great saphenous vein with diameter 5-10 mm, measured 3cm distal to the saphenofemoral junction in supine position. 3-Compressibility of GSV. 4-Intact deep vein system. 5-Reflux time of more than 1 s on duplex imaging. 6-Informed consent provided.
Exclusion criteria
1-Deep vein thrombosis and active superficial thrombophelebities 2-Arterial disease of lower limbs or ankle brachial index below 0.8 or both. 3-Highly tortuous GSV rending the vein unsuitable for catheter induction. 4-Pregnancy. 5-Secondary varicose veins. 6-Known allergy to polidocanol or to one of its constituents. 7-High risk of deep vein thrombosis to the following criteria:  Oral contraceptive  Obesity  Smoking  Immobility  Malignancy 9-Patients refuse to provide a written consent for treatment and follow up.
Methods

Patient evaluation:
After informed written consent, patients were subjected to the following: a) Clinical evaluation. b) Duplex assessment.
Statistical analysis
Data were analyzed using SPSS 16. Mean ± standard deviation was computed for age, weight and height. P-value of 0.05 or less was considered statistically significant. 
RESULTS
DISCUSSION
This clinical study showed that CDFS has acceptable results in the treatment of incompetent GSV. The complication rate was low. Events such as visual disturbance, migraine or chest problems which have been previously described as following foam sclerotherapy (8, 9, 10) could not be detected. The absence of early adverse effects of foam therapy may be attributed to the limited amount of foam injected in our patients.
In this study no cases of thromboembolic complications were remarked although reported in previous clinical series concerning foam sclerotherapy . Follow-up for 6-month period showed recanalization of saphenous trunks in about 16 % of duplex controlled treated limbs. This is comparable to other reports (12, 13, 14, 15) . The technique that has been adopted in our study proved to be of several potential advantages. The delivering catheter itself induces venospasm resulting in a high concentration of foam as well as an optimal contact to the vein wall.
Regarding the foam itself, Cavezzi and Tessari (11) had already reported that the characteristics of home-made foam greatly influence the choice of the gas component, the liquid-to-gas ratio and the type of syringes. Larger needles are preferred for injection of foam while long catheters seem to be a valid alternative use especially when combined with tumescence to minimize the saphenous diameter. The distribution of foam achieved by direct puncture technique is unpredictable (16, 17) . Direct puncture sclerotherapy may allow larger amounts of the foam to pass into the deep veins . This "spill-over" of foam occurs mainly via perforators of the thigh to the deep venous system and can potentially be reduced using catheter-directed delivery into defined vesselsegments and a low injection pressure under withdrawal of the catheter . However, this aspect needs further investigation.
Foam-sclerotherapy is often referred to as ultrasound-guided and controlled. This implies accuracy and safety. In most studies ultrasound is used to aid the puncture of the GSV and then to compress the saphenofemoral junction to prevent foam migration. However, the ultrasound transducer is also used to guide the foam using external massage pressure or "milking"-techniques . In our experience using ultrasound for these purposes is technically difficult. Careful delivery of foam to the intended site of action using a sheath along the length of the axial vein is technically easier and more reliable.
The immediate success rate and the degree of reflux after 6-month follow-up of catheterdirected foam sclerotherapy was comparable well with the results of ELT or RFA treatment . The high degree of patients` acceptance as well as the positive early results should be taken into consideration.
In conclusion, the use of this catheter based technique facilitates foam sclerotherapy with a high primary and acceptable short-term occlusion rates, and low numbers of complications. Further studies are required to evaluate how the migration of foam into the common femoral vein can be diminished and whether the techniques used in this study of leg elevation and manual compression add any advantage.
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